Market Tracker

07/22 5:16pm ET

Alere Inc (NYSE:ALR)

43.96
Delayed Data
As of Jul 22
 +0.16 / +0.37%
Today’s Change
31.96
Today|||52-Week Range
55.99
+12.46%
Year-to-Date
Abbott's Alere Deal Continues To Face Uncertainty
Jul 20 / TheStreet.com - Paid Partner Content
Alere Updates on 10K Filing, Reports Preliminary Q1 Figures
Jul 15 / Zacks.com - Paid Partner Content
The Reason Behind Alere Inc.'s Double-Digit Percentage Gain on Friday
Jul 15 / MotleyFool.com - Paid Partner Content
Why is Alere Inc. (ALR) up Today?
Jul 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close43.80
Today’s open43.85
Day’s range43.75 - 43.99
Volume360,229
Average volume (3 months)1,365,061
Market cap$3.8B
Dividend yield--
Data as of 4:02pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+87.61%
Earnings growth (this year)+6.21%
Earnings growth (next 5 years)+8.30%
Revenue growth (last year)-14.61%
P/E ratioNM
Price/Sales1.22
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp-0.14-0.13%
NEOGNeogen Corp+0.12+0.22%
AAAPAdvanced Accelerator...-0.18-0.59%
GHDXGenomic Health Inc-0.67-2.32%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$2.6B
Annual profit (last year)$9.9M
Net profit margin-6.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Namal Nawana
Senior Vice President-
Global Operations
Mark Gladwell
Corporate headquarters
Waltham, Massachusetts

Forecasts